Device having titania nanotube membrane for drug delivery

• US 9,814,867 B2
• Filed: 12/05/2012
• Issued: 11/14/2017
• Est. Priority Date: 12/05/2011
• Status: Active Grant

• Current Assignee: Nano Precision Medical, Inc.
• Original Assignee: Nano Precision Medical, Inc.
• Inventors: Mendelsohn, Adam D., Fischer, Kathleen E., Peng, Lily H., Fischer, William G.
• Primary Examiner(s): Katz, Vera
• Application Number:
  US14/362,554
• Publication Number:
  US 20140371687A1
• Time in Patent Office: 1,805 Days
• Field of Search: None
• CPC Class Codes: A61K 38/212 IFN-alpha
• CPC Class Codes: A61K 9/0024 Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue compositions for intravenous administration, normal injectable solutions or dispersions for, e.g. subcutaneous administration A61K9/0019; brain implants A61K9/0085; (coated) prostheses, catheters or stents A61L
• CPC Class Codes: A61K 9/0092 Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
• CPC Class Codes: A61K 9/4808 characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release capsules filled with granules or microparticles A61K9/16; filled with microcapsules or coated microparticles A61K9/50; with mixture of different granules, microcapsules, (coated) microparticles A61K9/5084
• CPC Class Codes: A61M 31/002 Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time artificial gland structures or devices A61F2/022; intra-uterine contraceptive devices A61F6/14; tampons for introducing into the vagina A61F13/20, A61L15/00; suppositories or bougies for intra-vaginal or intra-uterine application A61K9/02; physical forms of medicinal preparations for sustained or differential drug release A61K9/20, A61K9/50
• CPC Class Codes: B82Y 30/00 Nanotechnology for materials or surface science, e.g. nanocomposites
• CPC Class Codes: C25D 11/26 of refractory metals or alloys based thereon
• CPC Class Codes: C25D 11/34 of metals or alloys not provided for in groups C25D11/04 - C25D11/32
• CPC Class Codes: C25D 5/48 After-treatment of electroplated surfaces
• CPC Class Codes: C25D 5/50 by heat-treatment
• CPC Class Codes: F04C 2270/041 Controlled or regulated

Abstract

The present invention provides a device including a titania nanotube membrane having a plurality of titania nanotubes on a titanium substrate where the titania nanotubes are open at both ends and capable of allowing diffusion of liquids or solids from one side of the membrane to the other through the titania nanotubes. Methods of making the titania nanotube membrane are also provided.

Claims

1. A method of preparing a titania nanotube membrane, the method comprising:

growing a plurality of titania nanotubes on a first side of a titanium substrate under anodization conditions, such that a first end of each nanotube is closed and directly attached to the titanium substrate, and a second end of each nanotube is open; and

etching the titanium substrate on the side opposite the first side, under conditions sufficient to open the first end of a first group of the titania nanotubes, thereby preparing the titania nanotube membrane, wherein the nanotubes opened on the first end and the nanotubes opened on the second end is the only pathway for diffusion from one side of the titania nanotube membrane to the other, and wherein the first end of each nanotube is directly attached to the titanium substrate.

2. The method of claim 1, wherein the first end of a second group of the titania nanotubes remains closed.

3. The method of claim 1, wherein the growing step comprises:

contacting the first side of the titanium substrate with an anodization solution comprising a halogen ion, water and a water-miscible solvent.

4. The method of claim 3, wherein the anodization solution comprises ammonium fluoride.

5. The method of claim 3, wherein the water-miscible solvent is selected from the group consisting of ethanol, ethylene glycol, propylene glycol, and 1,3-propanediol.

6. The method of claim 3, wherein the anodization solvent comprises ammonium fluoride in an amount of from about 0.01 to about 5 wt %.

7. The method of claim 3, wherein the anodization solvent comprises water in an amount of from about 0.1 to about 50 wt %.

8. The method of claim 3, wherein the anodization solvent comprises water-miscible solvent in an amount of from about 50 to about 99 wt %.

9. The method of claim 3, wherein the anodization solvent comprises

ammonium fluoride in an amount from about 0.1 to about 1 wt %;

water in an amount of from about 1 to about 5 wt %; and

the water-miscible solvent in an amount of from about 95 to about 99 wt %.

10. The method of claim 1, wherein the method further comprises annealing the plurality of titania nanotubes on the titanium substrate.

11. The method of claim 10, wherein the annealing step comprises:

heating the plurality of titania nanotubes on the titanium substrate at a temperature of from about 200 to about 1000°

C.

12. The method of claim 11, wherein the heating is at a temperature of about 450°

C.

13. The method of claim 1, wherein the etching is performed using a deep reactive-ion etch.

14. A titania nanotube membrane prepared by the process of claim 1, the process comprising:

growing a plurality of titania nanotubes on a first side of a titanium substrate under anodization conditions, such that a first end of each nanotube is closed and directly attached to the titanium substrate and a second end of each nanotube is open; and

etching the titanium substrate on the side opposite the first side, under conditions sufficient to open the first end of a first group of the titania nanotubes, thereby preparing the titania nanotube membrane, wherein the nanotubes opened on the first end and the nanotubes opened on the second end is the only pathway for diffusion from one side of the titania nanotube membrane to the other, and wherein the first end of each nanotube is directly attached to the titanium substrate.

15. A device comprising:

a capsule suitable for implantation;

a reservoir encapsulated by the capsule, wherein the reservoir is suitable for containing a therapeutic agent; and

a titania nanotube membrane directly attached to a titanium substrate, wherein the titanium substrate is attached to the capsule such that the titanium substrate is in contact with the reservoir, wherein the titania nanotube membrane comprises a plurality of titania nanotubes directly attached to the titanium substrate and in fluid contact with the reservoir, and wherein the titania nanotube membrane is prepared by the method of claim 1,

such that the plurality of titania nanotubes is the only diffusion pathway out of the reservoir for the therapeutic agent.

16. The device of claim 15, wherein the capsule comprises titanium.

17. The device of claim 15, wherein the titania nanotubes have an internal diameter of from about 10 nm to 1000 nm.

18. The device of claim 15, wherein the titania nanotubes have a length of about 1 μ

m to about 100 μ

m.

19. The device of claim 15, wherein the titania nanotubes have an aspect ratio of about 10 to about 10,000.

20. The device of claim 15, wherein the therapeutic agent is selected from the group consisting of beta-glucocerobrosidase, interferon alpha, interferon beta, agasidase alpha, agasidase beta, exenatide, nutropin/somatropin, factor VIII, fondaparinux, aldesleukinand, risperidone, forigerimod, NP fusion proteins, IL-12, a melanocyte stimulating hormone, and bapineuzumab.

21. The device of claim 15, wherein the therapeutic agent is interferon alpha.

22. The device of claim 15, wherein the release of the therapeutic agent from the reservoir and through the titania nanotube membrane is a zero-order rate of release.

25. The titania nanotube membrane of claim 23, wherein the titania nanotube membrane is prepared by the method of claim 1.

23. A titania nanotube membrane comprising a plurality of titania nanotubes directly attached to a titanium substrate, wherein each nanotube has a first end and a second end such that both the first end and second end of a first group of the titania nanotubes are open, wherein the first group of nanotubes is the only pathway for diffusion from one side of the titania nanotube membrane to the other.

24. The titania nanotube membrane of claim 23, wherein the titania nanotube membrane further comprises a second group of the titania nanotubes each nanotube having a first end and a second end, wherein only the second end of the second group of the titania nanotubes are open.